Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: May 29, 2026

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Published on: July 23, 2016

Can leptin-derived sequence-modified nanoparticles be suitable tools for brain delivery?

Giovanni Tosi¹, Luca Badiali, Barbara Ruozi

¹Department of Pharmaceutical Sciences, University of Modena & Reggio Emilia, Via Campi, 41100 Modena, Italy. gtosi@unimore.it

Nanomedicine (London, England)

|October 1, 2011

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Retraction Note: MEK1/2 regulate normal BCR and ABL1 tumor-suppressor functions to dictate ATO response in TKI-resistant Ph+ leukemia.

Leukemia·2026

Same author

Quantitative computed tomography body composition analysis for risk stratification in bronchiectasis.

Respiratory research·2026

Same author

The molecular landscape of the C1498 murine acute myeloid leukemia cell line.

Biomarker research·2026

Same author

Patient's features, clinical patterns and outcomes of non-tuberculous mycobacteria infections: A 10-year retrospective analysis from a third level university hospital.

Journal of clinical tuberculosis and other mycobacterial diseases·2026

Same author

Lipidic nanomedicines enhance Hinokitiol activity on human primary macrophages from Ferroportin disease patients.

International journal of pharmaceutics·2025

Same author

Perceived HIV-related stigma: disparities between an Infectious Diseases Unit and other hospital departments.

AIDS research and therapy·2025

Modified nanoparticles carrying leptin's g21 sequence successfully crossed the blood-brain barrier in rats, demonstrating potential for brain drug delivery. These nanoparticles showed no appetite-suppressing effects, indicating safety for therapeutic applications.

Area of Science:

Nanotechnology
Neuroscience
Pharmacology

Background:

Brain drug delivery faces challenges due to the blood-brain barrier (BBB).
Nanoparticles (NPs) offer potential for targeted drug delivery.
Leptin's sequence g21 is explored for its potential in brain targeting.

Purpose of the Study:

To conjugate the leptin sequence 12-32 (g21) to poly-lactic-co-glycolic acid (PLGA) nanoparticles (NPs).
To evaluate the brain targeting capability of these modified NPs in rats after intravenous administration.

Main Methods:

Conjugation of g21 to tetramethylrhodamine-labeled NPs using Avidin-Biotin technology.
Intravenous injection of g21-labeled NPs into rats.
Evaluation of brain localization via confocal, fluorescence, and electron microscopy.

More Related Videos

A Simple Alternative to Stereotactic Injection for Brain Specific Knockdown of miRNA

A Simple Alternative to Stereotactic Injection for Brain Specific Knockdown of miRNA

Published on: December 26, 2015

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model

Published on: September 27, 2024

Related Experiment Videos

Last Updated: May 29, 2026

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Published on: July 23, 2016

A Simple Alternative to Stereotactic Injection for Brain Specific Knockdown of miRNA

A Simple Alternative to Stereotactic Injection for Brain Specific Knockdown of miRNA

Published on: December 26, 2015

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model

Published on: September 27, 2024

Biodistribution studies comparing modified and unmodified NPs.

Assessment of potential anorectic effects of g21-conjugated NPs.

Main Results:

g21-modified NPs successfully crossed the blood-brain barrier and entered the brain parenchyma.
Biodistribution revealed NP uptake in the liver and spleen, with specific brain localization only for g21-modified NPs.
Food intake experiments confirmed no anorectic effect from intravenous administration of g21-conjugated NPs.

Conclusions:

g21-modified NPs demonstrate the ability to cross the blood-brain barrier.
These novel modified NPs represent promising carrier systems for effective brain drug delivery.